Indeed, EGR1 has been associated with mood disorders and with SZ,4,11,12 and has been identified as an important target in the response to treatment.13,14 In addition, a growing number of studies have suggested that EGR3 is potentially involved with relevant pathways associated with major psychiatric disorders.15–20. This evidence concerns the gene EGR1 and psychiatric disorder.